Skip to main content

Day: April 26, 2021

Ørsted signs power purchase agreement with MSD

MSD enters into an agreement to purchase energy from the Armadillo Solar Center in Navarro County, Texas. With the PPA, Ørsted is extending its industrial customer base to the pharmaceutical industry. The Center is expected to be operational by early 2023. MSD, a biopharmaceutical company known as Merck & Co. Inc., Kenilworth New Jersey, in the US and Canada, has signed an agreement to purchase energy from the Armadillo Solar Center in Texas. “We’re happy to partner with MSD and expand our customer base to the pharmaceutical industry,” said Vishal Kapadia, Senior Vice President and Chief Commercial Officer of Onshore in Ørsted, continuing: “It’s exciting to join forces with them in their efforts to advance the use of carbon-free energy in the medical industry.” The Armadillo Solar Center will be based in Navarro County in Texas,...

Continue reading

Ørsted indgår elkøbsaftale med MSD

MSD indgår aftale om at købe energi fra Armadillo-solcelleanlægget i Navarro County i Texas i USA. Med denne elkøbsaftale (PPA) udvider Ørsted sin base af industrikunder til nu også at omfatte medicinalindustrien. Anlægget forventes at blive sat i drift i starten af 2023. MSD, en medicinalvirksomhed, der er kendt som Merck & Co. Inc., Kenilworth New Jersey, i USA og Canada, har indgået en aftale om at købe energi fra Ørsteds Armadillo-solcelleanlæg i Texas, USA. ”Vi er glade for at indgå dette samarbejde med MSD og udvide vores kundebase, så den nu også omfatter medicinalindustrien,” siger Vishal Kapadia, Senior Vice President og Chief Commercial Officer for Onshore i Ørsted. Han fortsætter: ”Vi ser frem til at samarbejde med dem i deres bestræbelser om at fremme brugen af CO2-fri energi i medicinalindustrien.” Armadillo-solcelleanlægget...

Continue reading

Non-invasive Prenatal Testing Market to Reach USD 13.16 Billion by 2028; Technological Intervention to Play a Massive Role in Growth, says Fortune Business Insights™

Pune, India, April 26, 2021 (GLOBE NEWSWIRE) — The global non-invasive prenatal testing (NIPT) market size is projected to reach USD 13.16 billion by the end of 2028. The presence of several large scale companies will have a positive impact on the growth of the market in the upcoming years. According to a report published by Fortune Business Insights, titled, “Non Invasive Prenatal Testing (NIPT) Market, 2021-2028,” the market was worth USD 3.48 billion in 2020 and will exhibit a CAGR of 18.1% during the forecast period, 2021-2028. Industry Developments: July 2019: Invitae announced that it will be acquiring Singular Bio, a company specializing in single-molecule cell-free DNA analysis. The collaboration will be aimed at developing non-invasive prenatal tests. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/non-invasive-prenatal-testing-market-100998 List...

Continue reading

Blue Vision A/S – forlængelse af bankgæld og optagelse af konvertible lån

Dato: 26. april  2021 Årets meddelelse nr.: 13 Blue Vision A/S gav i resumeet til årsrapporten for 2020, offentliggjort den 31. marts 2021, blandt andet oplysning om, at selskabets prekære likviditetssituation ville blive søgt imødekommet ved yderligere kreditorforhandlinger samt kapitalfremskaffelse herunder i form af konvertible lån. Der kan således gives orientering om, at som et resultat af bestræbelserne – og ikke mindst værdsat velvilje blandt Blue Vision A/S’ samarbejdspartnere – har selskabet:indgået aftaler for så vidt angår bankgæld stor 8,5 mio. kr. således, at gælden tidligst forfalder i 2022,optaget konvertible lån på ca. kr. 3,0 mio. kr. jf. bemyndigelserne givet i vedtægternes paragraf 4.3.A og 4.3.B, indgået kreditoraftale for så vidt angår 2,4 mio. kr. således at forfaldsdatoen forlænges til primo...

Continue reading

O-I Glass Announces Agreement of Potential Plan of Reorganization for Paddock Subsidiary

PERRYSBURG, Ohio, April 26, 2021 (GLOBE NEWSWIRE) — O-I Glass, Inc. (“O-I Glass” or “O-I”) today announced that its wholly owned subsidiary, Paddock Enterprises, LLC (“Paddock”), has reached an agreement in principle for a consensual plan of reorganization under section 524(g) of the Bankruptcy Code. Paddock, the Official Committee of Asbestos Personal Injury Claimants (the “ACC”), and the legal representative for the future asbestos personal injury claimants (the “FCR”) all agreed to accept the terms of a mediator’s proposal regarding a potential consensual plan of reorganization for Paddock. O-I Glass supports the agreement among Paddock, the ACC and the FCR that follows a successful court-approved mediation process conducted by Kenneth Feinberg and the Honorable Layn R. Phillips in connection with Paddock’s ongoing Chapter 11...

Continue reading

Auxly Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021

TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a consumer packaged goods company in the cannabis products market, today released its fourth quarter and full year 2020 financial results. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts. 2020 HighlightsRecorded net revenues of $50.8 million in 2020, including $46.6 million in cannabis net revenues, an increase of 508% compared to 2019. Fourth quarter net Cannabis revenues of $18.3 million. Achieved the #1 LP position in Canada for Cannabis 2.0 product sales1 in 2020 with approximately 14% market share in the category. Expanded into the...

Continue reading

Plateau Energy Metals Reminds Security Holders of Deadline to Vote at Special Meeting

TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Plateau Energy Metals Inc. (“Plateau” or the “Company”) (TSX-V: PLU | OTCQB: PLUUF) would like to remind all eligible shareholders and optionholders (collectively, the “Securityholders”) of the Company that the deadline to vote their common shares and stock options in advance of the special meeting (the “Special Meeting”) of Securityholders is 10:00 a.m. (Toronto time) on April 29, 2021. The Special Meeting will be held in virtual format on May 3, 2021 at 10:00 a.m. (Toronto time) to approve the Company’s business combination (the “Arrangement”) with American Lithium Corp. (“American Lithium”) announced February 9, 2021.   Securityholders are encouraged to review and consider the information circular in connection with the Special Meeting. A copy of the information circular and all other...

Continue reading

Emerging Markets Report: Salad Days Ahead for Lithium

ORLANDO, Fla., April 26, 2021 (GLOBE NEWSWIRE) — While doing our usual research for Lithium South Development Corporation (TSX-V: LIS) (OTCQB: LISMF) (Frankfurt OGPQ) a recent article from Forbes really stood out amid the various other commentaries and reporting. If you’re a fan of lithium companies like Lithium South Development Corp or the lithium industry, it’s a must read in full at this link. Short of that, let’s take a succinct look at how the author arrives at the conclusion that lithium is headed for very good times or ‘salad days’ as he calls them. Here are a few critical excerpts:The burgeoning green revolution is driving the need for lithium which is used in most Electric Vehicles (EV.) Lithium demand is expected to more than double by 2024. Europe now uses more lithium to power vehicles than diesel and gasoline may...

Continue reading

Emerging Markets Report: The Rich Get Richer

An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 26, 2021 (GLOBE NEWSWIRE) — Blockbuster news out of Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) this past weekend. As you’ll recall Core One is a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market. The Company already has an impressive footprint in the rapidly expanding psychedelic treatment category with novel drug delivery methods, therapies, and more. Most notably, the Company has developed a proprietary, patent-pending technique to create pharmaceutical grade psilocybin at a fraction of the price. That alone could be a game changer. But Saturday’s news regarding the signing of a Letter of Intent to acquire another company with a fantastic portfolio of psychedelic-based pharmaceuticals...

Continue reading

Tier-1 Telco in Latin America Awards Gilat Over $3M to Provide Broadband Connectivity in Support of Bridging the Digital Divide

PETAH TIKVA, Israel, April 26, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that a Tier-1 Telco in Latin America awarded Gilat over $3M to provide broadband connectivity over satellite to support bridging the digital divide. The project includes thousands of VSATs to be deployed in remote schools to further children’s education in Latin America and is expected to expand further. Gilat’s SkyEdge II-c network was chosen due to its vast experience and expertise in delivering high-quality broadband connectivity and in deploying tens of thousands of VSATs for Universal Service Obligation (USO) projects throughout Latin America and in the world at large. A photo accompanying this announcement is available...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.